Our Team

As Pres­i­dent and CEO, Kevin has led the Well­doc® team in the suc­cess­ful launch and con­tin­ued devel­op­ment of dig­i­tal ther­a­peu­tics for peo­ple liv­ing with chron­ic dis­ease. Kevin over­sees all Well­doc busi­ness relat­ed to enter­prise strat­e­gy and has engi­neered an inno­v­a­tive com­mer­cial approach to posi­tion Well­Doc in the mar­ket­place to attract key investors, like John­son & John­son, Sam­sung and Mer­ck GHI. He has also estab­lished key strate­gic part­ner­ships that include John­son & John­son, Sam­sung, Sol­era, Vol­un­tis and Amer­i­can Well.

Pri­or to join­ing Well­doc in 2014, Kevin had an exten­sive career in biotech and phar­ma­ceu­ti­cals. He held senior exec­u­tive roles at Human Genome Sci­ences, Genen­tech and Abbott after begin­ning his career at Bax­ter Health­care.